David Blatteis Email & Phone Number

Philosophy: David's philosophy is to develop a reliable relationship with his clients by understanding their business environment and corporate needs and by accomplishing the client’s goals in an efficient and effective manner. He has served as outside general counsel for public and private healthcare companies for over 20 years.Representative Clients:David represents pharmaceutical companies, pharmaceutical service providers, medical device companies and other healthcare organizations, including leading contract sales organizations which provide sales, marketing, technology and compliance solutions to the world’s largest pharmaceutical companies. David negotiates and drafts major field force, sales force automation, technology, joint venture and risk share agreements, resulting in significant revenue for these clients. Specialties: corporate law, pharmaceutical and medical device, health care, securities, mergers and acquisitions, corporate governance, structuring, corporate restructurings, purchase and sale of operations, stock and asset transactions, negotiation, shareholders, operations, licensing, distribution, confidentiality agreements, employment agreements, bank and corporate financing.

• 

  Member - Business And Healthcare

  Norris Mclaughlin, P.A.

  2000 - Present - Bridgewater, New Jersey, United States

  Member of Management Committee | Co-Chair Business Law Group Corporate attorney, specializing in health care, mergers and acquisitions, corporate governance and various other general corporate matters. General corporate practice, including structuring, organization and maintenance of corporate entities. Assists clients with mergers and acquisitions, corporate restructurings, and the purchase and sale of operations by means of stock and asset transactions. Regularly negotiates and prepares shareholder, operating, license, distribution, confidentiality and employment agreements. Negotiate and prepare documentation in connection with development and later-stage debt and equity venture capital transactions, including private placements and bank and corporate financings.